Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling
Joseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al. · 2007
Read Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling by Joseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001313.txt.
Description
Nitrosylcobalamin is a drug built on vitamin B12 that delivers nitric oxide preferentially to tumor cells, which display extra B12 receptors. Joseph Bauer and colleagues tested it alongside standard chemotherapy agents, in a 2007 PLOS ONE article. The compound induces apoptosis through one pathway and inhibits survival signaling in cancer cells.
The authors report that nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling. Two attacks are better than one if they do not simply add toxicity. Their study explores whether the B12-based pro-drug makes established drugs work harder against tumors.
Catalog record
| CREATOR | Joseph A. Bauer, Joseph A. Lupica, Heidi Szugye et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001313